Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

4
Ryman Hospitality Properties, Inc. Announces Online Registration for Institutional Investor and Analyst Day – September 13 & 14, 2018

2018-07-11 globenewswire
NASHVILLE, Tenn., July 11, 2018 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE:RHP) announced today that the online registration for its Institutional Investor and Analyst Day on Thursday, September 13, and Friday, September 14 is now open. The event will take place at the Gaylord Opryland Resort and Convention Center in Nashville, TN and space is limited.
MAR RHP MAR.WI

4
Ryman Hospitality Properties Announces Second Quarter 2018 Earnings Conference Call – Tuesday, August 7, 2018, 11:00 A.M. ET

2018-07-05 globenewswire
NASHVILLE, Tenn., July 05, 2018 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE:RHP), a lodging real estate investment trust ("REIT") specializing in group-oriented, destination hotel assets in urban and resort markets, announced today that it will release its second quarter 2018 earnings results before the market opens on Tuesday, August 7, 2018. Management will hold a conference call to discuss the quarter's results at 11:00 a.
MAR RHP MAR.WI

1
RHP / Ryman Hospitality Properties, Inc. FORM 8-K (Current Report)

2018-06-27 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
RHP

50
United Community Banks downgraded to hold vs. buy at SunTrust Robinson Humphrey

2018-06-26 marketwatch
KS Bancorp: Shareholders Should Reject The Proposal Of Conversion To Delaware Corporation And Pressure The Management For A Sale
SBNY SBNYW HOPE GPRE IEX REXR.PRA UE.WI RHP ETH UBSH NFX UE HCKT REXR.PRB DST IPGP UCBI REXR UNB RPM AKAM GHDX ECPG

1
RHP / Ryman Hospitality Properties, Inc. FORM 11-K

2018-06-22 sec.gov
Form 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.
RHP

2
Ryman Hospitality Properties, Inc. Declares Second Quarter Dividend

2018-06-18 globenewswire
NASHVILLE, Tenn., June 18, 2018 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE:RHP) today announced that its Board of Directors declared a cash dividend of $0.85 per share of common stock payable on July 16, 2018 to stockholders of record on June 29, 2018.
MAR RHP MAR.WI

26
Panning For Gold: 'If You Build It, They Will Come'

2018-06-12 seekingalpha
This article is the first in a series called "Panning For Gold", in which I will explore the specialty REITs.
PK MAR SRG APLE CLDT SRG.PRA RHP FCPT PEB MAR.WI

3
Time To Take Another Bite At Apple

2018-06-11 seekingalpha
APLE has outperformed CLDT and I thought it would be a good time to write an update.
DTK RHP HLT

1
Ryman Hospitality Properties: Unique Assets, Fairly Valued

2018-06-08 seekingalpha
Ryman Hospitality Properties stock price has been rising since the company became a REIT in 2013.
RHP

2
Ryman Hospitality Properties, Inc. Announces Save-the-Date for Institutional Investor and Analyst Day – September 13 & 14, 2018

2018-06-04 globenewswire
NASHVILLE, Tenn., June 04, 2018 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE:RHP), a lodging real estate investment trust ("REIT") specializing in group-oriented, destination hotel assets in urban and resort markets, today announced the Save-the-Date for its Institutional Investor and Analyst Day on Thursday, September 13 and Friday, September 14.
MAR RHP MAR.WI

8
Tier Reit upgraded to overweight from neutral at J.P. Morgan

2018-05-16 marketwatch
Recent Analysis Shows Nokia, Ryman Hospitality Properties, Vista Gold, TIER REIT, Oritani Financial, and Western Gas Equity Partners, LP Market Influences -- Renewed Outlook, Key Drivers of Growth
VGZ TIER RHP VGZ WGP ORIT

14
7 Hotel Stocks to Buy Ranked From Best to Worst

2018-05-11 investorplace
It’s that time of the year again when Americans get in their cars and hit the road for a week or two of family fun.
PK MAR MGM HGV MTN MGP RCL RHP LVS HLT MAR.WI

10
Maintaining Strong Buy Thesis For City Office

2018-05-08 seekingalpha
Owning small-cap stocks creates volatility and one way for me to smooth out the instability is to reduce exposure to one company.
GMRE.PRA DOC STAG.PRB HTA STAG.PRC RHP CIO.PRA CYORP GMRE CIO STAG STAG.PRA

1
RHP / Ryman Hospitality Properties, Inc. FORM 8-K (Current Report)

2018-05-04 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
RHP

1
RHP / Ryman Hospitality Properties, Inc. FORM 10-Q (Quarterly Report)

2018-05-03 sec.gov
Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.
RHP

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to RHP / Ryman Hospitality Properties, Inc. on message board site Silicon Investor.

RHPS: R.H. Phillips, Inc.
CUSIP: 78377T107